Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MPO | P05164 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9821030 | 0.77 | TLR8 (0.49) | GAAMAPTSMN1; SMN2MPOKDM4E | |
| SCHEMBL3970688 | 0.73 | PDE10A (0.56) | GAAMAPTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL5501886 | 0.71 | SMN1; SMN2 (0.70) | GAAMAPTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL12767717 | 0.70 | ERN1 (0.54) | GAASMN1; SMN2KDM4EALDH1A1HPGD | |
| SCHEMBL9611245 | 0.67 | KDM4E (0.57) | GAAMAPTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4602308 | 0.67 | MAPT (0.49) | GAAMAPTMPOKMT2AMEN1 | |
| SCHEMBL5852507 | 0.66 | KDM4E (0.52) | GAAMAPTSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL23023094 | 0.66 | GAA (0.51) | GAAMAPTSMN1; SMN2MPOKMT2A | |
| Alcohol SCHEMBL17927662 | 0.66 | MEN1 (0.77) | GAAMAPTSMN1; SMN2MPOKMT2A | |
| SCHEMBL27228 | 0.65 | GAA (0.95) | GAAMAPTMPOKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4789678-A | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1988-12-06 | — | — | US | claimed |
| EP-0258755-B1 | ALPHA-ALKYL-4-AMINO-3-QUINOLINE-METHANOLS AND 1-(4-ARALKYLAMINO-3-QUINOLINYL) ALKANONES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| US-4840972-A | Relief from memory dysfunction with α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1989-06-20 | — | — | US | disclosed |
| US-4789678-A | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1988-12-06 | — | — | US | disclosed |
| EP-0258755-A1 | Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-03-09 | — | — | EP | disclosed |